代表論文 (Journal Publication)

1. Wey SP, Weng CC, Lin KJ, Yao CH, Yen TC, Kung HF, Skovronsky D, Kung MP. Validation of an 18F-labeled biphenylalkyne as a positron emission tomography imaging agent for β-amyloid plaques. Nuclear Medicine and Biology 2009;36:411-417.

2. Yao CH, Lin KJ, Weng CC, Hsiao IT, Ting YS, Yen TC, Jan TR, Skovronsky D, Kung MP, Wey SP.  GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging β-amyloid plaques in human brain. Applied Radiation and Isotopes 2010;68(12):2293-2297.

3. Weng CC, Chen ZA, Chao KT, Ee TW, Lin KJ, Chan MH, Hsiao T, Yen TC, Kung MP, Hsu CH, Wey SP. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. PloS one. 2017 Mar 3;12(3):e0173503.

4. Weng CC, Huang SL, Chen ZA, Lin KJ, Hsiao T, Yen TC, Kung MP, Wey SP, Hsu CH. [18F] FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease. Annals of Nuclear Medicine. 2017 Apr 27:1-8.

5. Sellmyer MA, Lee I, Hou C, Weng CC, Li S, Lieberman BP, Zeng C, Mankoff DA, Mach RH. Bacterial infection imaging with [18F] fluoropropyl-trimethoprim. Proceedings of the National Academy of Sciences. 2017 Aug 1;114(31):8372-7. 

所有發表期刊論文: https://reurl.cc/332KaV